Introduction
Patients and methods Mononuclear cells were separated from sterile heparinised blood by density gradient centrifugation as described by Boyum.5 The cells collected at the interphase were washed three times with Hank's balanced salt solution (Flow Laboratories). Prepared lymphocytes were suspended at a final concentration of 106/ml in RPMI 1640 medium supplemented with 20%o AB serum, L-glutamine, penicillin, and streptomycin. The cells were placed in microtitre plates and mitogens and antigen at different concentrations were added. The plates were incubated at 37°C in a moist 5% C02/950o air atmosphere for five days and pulsed with 0 5 ,u Ci/well of 3H thymidine (Radiochemical Centre, Amersham, England) for the last 18 hours; the cultures were then harvested on glass-fibre filter paper using an automatic cell harvester (Flow Laboratories) and 3H thymidine uptake was measured on a P-liquid scintillation counter.
Results
The responses to the different mitogens are shown in the table. In every case there was a strongly positive response to PHA and PPD indicating normal T-cell function, and no significant difference in this response was evident between the patients and the controls. With purified HBsAg, however, a response occurred in only one of 15 patients, but three of the six controls who had recovered from acute type B hepatitis responded. The counts were between 5 000 and 10 000 cpm in two patients and more than 10 000 cpm in the third. None of the six healthy HBsAgnegative and anti-HBs-negative controls responded to this antigen.
Discussion
This study shows that in this well-defined group of male homosexual patients with high titres of serum HBsAg, detectable HBeAg, and abnormal liver function a normal non-specific cellular immune response to PHA and PPD occurred, despite a previous report to the contrary.3 A specific CMI response to HBsAg develops in the recovery phase of acute type-B hepatitis in some, but not all, patients and there appears to be a specific defect in this response in asymptomatic healthy carriers. 
